AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Velga-M 500 Tablet

Prescription Icon
Prescription Required

Marketer

Allegiant Biotech

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Velga-M 500 Tablet

Diabetica-Duo 500mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabetica-Duo 500mg may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and other medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar control lessens the risk of future complications. Maintaining the prescribed diet and exercise plan is crucial. Lifestyle choices significantly influence diabetes management. Common adverse effects include nausea, vomiting, diarrhea, abdominal distress, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; recognition and management of hypoglycemia are essential. This medication is not universally suitable. Prior to commencing treatment, disclose any history of hepatic, renal, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel. Inform your physician of all medications to ensure compatibility and safety. Alcohol should be limited due to its hypoglycemic effect. Your physician will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Velga-M 500 Tablet

No information provided. Please provide the text you wish me to rewrite.

Uses of Velga-M 500 Tablet

Managing type 2 diabetes

Major Benefits of Velga-M 500 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Velga-M 500 Tablet with a meal.

Common Side effects of Velga-M 500 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Velga-M 500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Velga-M 500 Tablet with a meal.

How Velga-M 500 Tablet works:

Metformin and vildagliptin are combined in the Velga-M 500 Tablet to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Velga-M 500 Tablet and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Velga-M 500 Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Velga-M 500 Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Velga-M 500 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.

LiverLiverUNSAFE

Individuals with liver impairment should likely refrain from using Velga-M 500 Tablets due to potential safety risks. Medical advice is recommended.

What if you forget to take Velga-M 500 Tablet :

Should you forget a Velga-M 500 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Velga-M 500 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Medication

FAQs on Velga-M 500 Tablet

Velga-M 500 Tablet rarely causes hypoglycemia (low blood sugar) by itself. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Regular blood sugar monitoring is therefore crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Nausea and vomiting are possible side effects of Velga-M 500 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take additional medication without your doctor's approval.
Velga-M 500 Tablet is contraindicated in patients allergic to its components or excipients. It should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and ensure it's inaccessible to children, pets, and others.
Velga-M 500 Tablet combines metformin, a biguanide that reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity, with vildagliptin, a DPP-4 inhibitor that boosts pancreatic insulin release. This combination is contraindicated for individuals under 18.
Velga-M 500 Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Velga-M 500 Tablet and seek immediate medical attention.
Prolonged Velga-M 500 Tablet use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Velga-M 500 Tablet as directed by your doctor is safe. However, even with proper dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if taking insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Velga-M 500 Tablet
139
MRP 161
13% off